Purpose: To determine the current management pattern for hordeolum and chalazion among members of the Korean Society of Ophthalmic Plastic and Reconstructive Surgery (KSOPRS). Methods: An anonymous web-based survey was emailed to 260 current members of the KSOPRS. The survey comprised five sections: differential diagnosis, treatment strategies for hordeolum, treatment strategies for chalazion, postsurgical care, and pediatric-specific approaches. Results: Eighty KSOPRS members participated in this study (response rate, 30.8%). Redness, swelling, and pain were the most important factors for differentiating hordeolum from chalazion. For hordeolum, topical antibiotics are preferred by 59 respondents (73.8%), with 49 (83.7%) considering them effective. Most (62 respondents, 77.6%) pursue nonsurgical treatment for 5 to 14 days before considering incision and curettage. For chalazion, treatment practices are split between conservative management and invasive methods. Intralesional steroid injections are recommended by 55 respondents (68.8%), with a preference for diluted triamcinolone acetonide. Relative to hordeolum, chalazion treatment involves less frequent antibiotic use, with only 21 respondents (26.3%) always recommending antibiotic ointments. Tissue biopsy is considered for abnormal changes in the surrounding tissues (72 respondents, 90.0%) and frequent recurrence (46 respondents, 57.5%). The practices differ between pediatric and adult cases among 38 respondents (47.5%), with 31 (81.4%) extending conservative management and delaying surgical interventions in pediatric cases. Anesthesia preferences for pediatric cases varied, with 40 respondents (50.0%) favoring local anesthesia, 19 (23.8%) opting for monitored anesthesia care, and 13 (16.2%) choosing general anesthesia. Conclusions This survey of the management of hordeolum and chalazion by KSOPRS members has revealed several interesting common practices that are considered valuable by current practitioners.

Purpose: To determine the current management pattern for hordeolum and chalazion among members of the Korean Society of Ophthalmic Plastic and Reconstructive Surgery (KSOPRS). Methods: An anonymous web-based survey was emailed to 260 current members of the KSOPRS. The survey comprised five sections: differential diagnosis, treatment strategies for hordeolum, treatment strategies for chalazion, postsurgical care, and pediatric-specific approaches. Results: Eighty KSOPRS members participated in this study (response rate, 30.8%). Redness, swelling, and pain were the most important factors for differentiating hordeolum from chalazion. For hordeolum, topical antibiotics are preferred by 59 respondents (73.8%), with 49 (83.7%) considering them effective. Most (62 respondents, 77.6%) pursue nonsurgical treatment for 5 to 14 days before considering incision and curettage. For chalazion, treatment practices are split between conservative management and invasive methods. Intralesional steroid injections are recommended by 55 respondents (68.8%), with a preference for diluted triamcinolone acetonide. Relative to hordeolum, chalazion treatment involves less frequent antibiotic use, with only 21 respondents (26.3%) always recommending antibiotic ointments. Tissue biopsy is considered for abnormal changes in the surrounding tissues (72 respondents, 90.0%) and frequent recurrence (46 respondents, 57.5%). The practices differ between pediatric and adult cases among 38 respondents (47.5%), with 31 (81.4%) extending conservative management and delaying surgical interventions in pediatric cases. Anesthesia preferences for pediatric cases varied, with 40 respondents (50.0%) favoring local anesthesia, 19 (23.8%) opting for monitored anesthesia care, and 13 (16.2%) choosing general anesthesia. Conclusions This survey of the management of hordeolum and chalazion by KSOPRS members has revealed several interesting common practices that are considered valuable by current practitioners.

Purpose: To determine the current management pattern for hordeolum and chalazion among members of the Korean Society of Ophthalmic Plastic and Reconstructive Surgery (KSOPRS). Methods: An anonymous web-based survey was emailed to 260 current members of the KSOPRS. The survey comprised five sections: differential diagnosis, treatment strategies for hordeolum, treatment strategies for chalazion, postsurgical care, and pediatric-specific approaches. Results: Eighty KSOPRS members participated in this study (response rate, 30.8%). Redness, swelling, and pain were the most important factors for differentiating hordeolum from chalazion. For hordeolum, topical antibiotics are preferred by 59 respondents (73.8%), with 49 (83.7%) considering them effective. Most (62 respondents, 77.6%) pursue nonsurgical treatment for 5 to 14 days before considering incision and curettage. For chalazion, treatment practices are split between conservative management and invasive methods. Intralesional steroid injections are recommended by 55 respondents (68.8%), with a preference for diluted triamcinolone acetonide. Relative to hordeolum, chalazion treatment involves less frequent antibiotic use, with only 21 respondents (26.3%) always recommending antibiotic ointments. Tissue biopsy is considered for abnormal changes in the surrounding tissues (72 respondents, 90.0%) and frequent recurrence (46 respondents, 57.5%). The practices differ between pediatric and adult cases among 38 respondents (47.5%), with 31 (81.4%) extending conservative management and delaying surgical interventions in pediatric cases. Anesthesia preferences for pediatric cases varied, with 40 respondents (50.0%) favoring local anesthesia, 19 (23.8%) opting for monitored anesthesia care, and 13 (16.2%) choosing general anesthesia. Conclusions This survey of the management of hordeolum and chalazion by KSOPRS members has revealed several interesting common practices that are considered valuable by current practitioners.

Purpose: We assessed the indications, efficacy, safety, and durability of hyaluronic acid gel filler injections in the periorbital region. Efficacy was evaluated through subjective patient satisfaction and objective symptom improvement. Methods: We conducted a retrospective analysis of the medical records of patients who underwent periorbital hyaluronic acid gel filler injections between February 2011 and June 2023. Patient demographics, indications for treatment, pre-injection symptoms, post-injection outcomes (including patient satisfaction), complications, and filler durability were collected and analyzed. Results: In total, 125 patients underwent 177 injection sessions. The mean age of patients was 49.0 years, with female predominance (71.2%). The most common indications were lid retraction (26.55%), enophthalmos (22.03%), and tear trough deformity (12.99%). Overall patient satisfaction was high (89.27%), and undercorrection was the primary reason for dissatisfaction (10/177); subsequent injections successfully addressed undercorrection in all patients. Symptom improvement was observed in 94.35% of injections, and 7 cases required surgery for persistent symptoms. Enophthalmos correction was 1.07 mm per injection and 1.15 mm per 1 cc of filler. Lid retraction improved by 1.41 ± 0.82 mm with an average of 0.51 ± 0.36 cc of filler per session. Common complications included pain, bruising, nausea, vomiting, and swelling. The mean filler durability was 46.3 weeks. Conclusions Lid retraction, enophthalmos, and tear trough deformity were common indications for periorbital hyaluronic acid gel filler injections. Most patients reported symptom improvement and high satisfaction. These findings suggest that periorbital filler injections can be a safe and effective outpatient treatment option for various periorbital conditions.

Purpose: We assessed the indications, efficacy, safety, and durability of hyaluronic acid gel filler injections in the periorbital region. Efficacy was evaluated through subjective patient satisfaction and objective symptom improvement. Methods: We conducted a retrospective analysis of the medical records of patients who underwent periorbital hyaluronic acid gel filler injections between February 2011 and June 2023. Patient demographics, indications for treatment, pre-injection symptoms, post-injection outcomes (including patient satisfaction), complications, and filler durability were collected and analyzed. Results: In total, 125 patients underwent 177 injection sessions. The mean age of patients was 49.0 years, with female predominance (71.2%). The most common indications were lid retraction (26.55%), enophthalmos (22.03%), and tear trough deformity (12.99%). Overall patient satisfaction was high (89.27%), and undercorrection was the primary reason for dissatisfaction (10/177); subsequent injections successfully addressed undercorrection in all patients. Symptom improvement was observed in 94.35% of injections, and 7 cases required surgery for persistent symptoms. Enophthalmos correction was 1.07 mm per injection and 1.15 mm per 1 cc of filler. Lid retraction improved by 1.41 ± 0.82 mm with an average of 0.51 ± 0.36 cc of filler per session. Common complications included pain, bruising, nausea, vomiting, and swelling. The mean filler durability was 46.3 weeks. Conclusions Lid retraction, enophthalmos, and tear trough deformity were common indications for periorbital hyaluronic acid gel filler injections. Most patients reported symptom improvement and high satisfaction. These findings suggest that periorbital filler injections can be a safe and effective outpatient treatment option for various periorbital conditions.

Purpose: To determine the current management pattern for hordeolum and chalazion among members of the Korean Society of Ophthalmic Plastic and Reconstructive Surgery (KSOPRS). Methods: An anonymous web-based survey was emailed to 260 current members of the KSOPRS. The survey comprised five sections: differential diagnosis, treatment strategies for hordeolum, treatment strategies for chalazion, postsurgical care, and pediatric-specific approaches. Results: Eighty KSOPRS members participated in this study (response rate, 30.8%). Redness, swelling, and pain were the most important factors for differentiating hordeolum from chalazion. For hordeolum, topical antibiotics are preferred by 59 respondents (73.8%), with 49 (83.7%) considering them effective. Most (62 respondents, 77.6%) pursue nonsurgical treatment for 5 to 14 days before considering incision and curettage. For chalazion, treatment practices are split between conservative management and invasive methods. Intralesional steroid injections are recommended by 55 respondents (68.8%), with a preference for diluted triamcinolone acetonide. Relative to hordeolum, chalazion treatment involves less frequent antibiotic use, with only 21 respondents (26.3%) always recommending antibiotic ointments. Tissue biopsy is considered for abnormal changes in the surrounding tissues (72 respondents, 90.0%) and frequent recurrence (46 respondents, 57.5%). The practices differ between pediatric and adult cases among 38 respondents (47.5%), with 31 (81.4%) extending conservative management and delaying surgical interventions in pediatric cases. Anesthesia preferences for pediatric cases varied, with 40 respondents (50.0%) favoring local anesthesia, 19 (23.8%) opting for monitored anesthesia care, and 13 (16.2%) choosing general anesthesia. Conclusions This survey of the management of hordeolum and chalazion by KSOPRS members has revealed several interesting common practices that are considered valuable by current practitioners.

Purpose: We assessed the indications, efficacy, safety, and durability of hyaluronic acid gel filler injections in the periorbital region. Efficacy was evaluated through subjective patient satisfaction and objective symptom improvement. Methods: We conducted a retrospective analysis of the medical records of patients who underwent periorbital hyaluronic acid gel filler injections between February 2011 and June 2023. Patient demographics, indications for treatment, pre-injection symptoms, post-injection outcomes (including patient satisfaction), complications, and filler durability were collected and analyzed. Results: In total, 125 patients underwent 177 injection sessions. The mean age of patients was 49.0 years, with female predominance (71.2%). The most common indications were lid retraction (26.55%), enophthalmos (22.03%), and tear trough deformity (12.99%). Overall patient satisfaction was high (89.27%), and undercorrection was the primary reason for dissatisfaction (10/177); subsequent injections successfully addressed undercorrection in all patients. Symptom improvement was observed in 94.35% of injections, and 7 cases required surgery for persistent symptoms. Enophthalmos correction was 1.07 mm per injection and 1.15 mm per 1 cc of filler. Lid retraction improved by 1.41 ± 0.82 mm with an average of 0.51 ± 0.36 cc of filler per session. Common complications included pain, bruising, nausea, vomiting, and swelling. The mean filler durability was 46.3 weeks. Conclusions Lid retraction, enophthalmos, and tear trough deformity were common indications for periorbital hyaluronic acid gel filler injections. Most patients reported symptom improvement and high satisfaction. These findings suggest that periorbital filler injections can be a safe and effective outpatient treatment option for various periorbital conditions.

Purpose: To determine the current management pattern for hordeolum and chalazion among members of the Korean Society of Ophthalmic Plastic and Reconstructive Surgery (KSOPRS). Methods: An anonymous web-based survey was emailed to 260 current members of the KSOPRS. The survey comprised five sections: differential diagnosis, treatment strategies for hordeolum, treatment strategies for chalazion, postsurgical care, and pediatric-specific approaches. Results: Eighty KSOPRS members participated in this study (response rate, 30.8%). Redness, swelling, and pain were the most important factors for differentiating hordeolum from chalazion. For hordeolum, topical antibiotics are preferred by 59 respondents (73.8%), with 49 (83.7%) considering them effective. Most (62 respondents, 77.6%) pursue nonsurgical treatment for 5 to 14 days before considering incision and curettage. For chalazion, treatment practices are split between conservative management and invasive methods. Intralesional steroid injections are recommended by 55 respondents (68.8%), with a preference for diluted triamcinolone acetonide. Relative to hordeolum, chalazion treatment involves less frequent antibiotic use, with only 21 respondents (26.3%) always recommending antibiotic ointments. Tissue biopsy is considered for abnormal changes in the surrounding tissues (72 respondents, 90.0%) and frequent recurrence (46 respondents, 57.5%). The practices differ between pediatric and adult cases among 38 respondents (47.5%), with 31 (81.4%) extending conservative management and delaying surgical interventions in pediatric cases. Anesthesia preferences for pediatric cases varied, with 40 respondents (50.0%) favoring local anesthesia, 19 (23.8%) opting for monitored anesthesia care, and 13 (16.2%) choosing general anesthesia. Conclusions This survey of the management of hordeolum and chalazion by KSOPRS members has revealed several interesting common practices that are considered valuable by current practitioners.

Purpose: A systematic review of the literature on diagnostic and therapeutic indications, techniques, and complications of dacryoendoscopy (DE) was performed. Methods: The authors performed a PubMed search of articles published in English on DE. Data were collected and classified according to the categories of the disease. The clinical outcomes and limitations were particularly analyzed. Results: The lacrimal drainage system from the canaliculus to the inferior meatus could be examined based on the specific anatomical features by DE. The canalicular mucosa is smooth and brightly colored, the lacrimal sac shows covering mucosa with good vascularization and the nasolacrimal duct is lined with bright tubular mucosal folds. DE allows direct visualization of the detailed internal condition of the lacrimal disorders, to directly diagnose the site of obstruction with accuracy and address the causes and recanalize the lacrimal drainage system using assisted micro lacrimal surgical instruments in the tearing patients. Conclusions Better visualization of the lacrimal canal with DE improves the understanding of physiology and precise identification of the obstructing lesions, both of which are the key to a comprehensive management for the tearing patients.

Purpose: To introduce punch biopsy, which can be easily performed in an outpatient setting, and to evaluate its clinical usefulness. Methods: A retrospective study was performed in 33 patients with atypical eyelid disorders who underwent punch biopsy. Results: This study included 33 eyes (33 patients; male:female = 12:21) with a mean age of 57.27 ± 19.12 years. There were 19 (57.6%) right eye, 14 (42.4%) left eye, 15 (45.5%) upper eyelid, and 18 (54.5%) lower eyelid lesions. The biopsy approaches were percutaneous and transconjunctival in 24 (72.7%) and nine (27.3%) eyes, respectively. Benign and malignant lesions were found in 21 (63.6%) and 12 (36.4%) eyes, respectively. The benign lesions included chalazion (52.4%), acute and chronic inflammation (23.8%), acanthosis (4.8%), and ectopic cillia (4.8%), and were treated conservatively by intralesional steroid injections or incision and drainage. The malignant lesions included sebaceous carcinomas (33.3%), squamous cell carcinomas (25%), and basal cell carcinomas (16.7%), with various treatments, including surgical resections, chemotherapy, and radiation therapy. Conclusions Punch biopsy is a safe and quick procedure that can easily be performed in the office setting for patients who require a pathologic diagnosis for eyelid diseases, including malignancies. It may be useful for diagnosis and treatment planning.